AV Medical Technologies Ltd.

www.a-vmedical.com

High-Tech Company

Acquired by Medtronic

TECH VERTICALS

Catheters, Healthtech, Life Sciences, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	Initial Revenues
Established	2012
Number of Employees	5
Reg. Number:	abCDe

DESCRIPTION

AV Medical is dedicated to the development of advanced and efficient solutions in catheter-based interventions. The company is focusing on its flagship catheter, the ChameleonTM, targeted for dialysis patients undergoing routine angioplasty procedures. Over 3.7M patients worldwide suffer from irreversible kidney failure or end-stage renal disease (ESRD) and need dialysis or a kidney transplant to survive. Most patients on dialysis require angioplasty by balloon catheter to maintain adequate blood flow to their access site. AV Medical develops and commercializes the ChameleonTM PTA balloon catheter with SupervisionTM technology as an answer to this market’s growing needs. ChameleonTM provides more efficient angioplasty procedures that can potentially enhance both patient and operator safety.

ChameleonTM has been clinically tested in various types of dialysis access procedures.

TECHNOLOGY

The Chameleon Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter is an over-the-wire, multi-lumen balloon catheter.

The Chameleon PTA Catheter is indicated for use in Percutaneous Transluminal Angioplasty of the femoral, iliac, and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This
catheter is not for use in coronary arteries.

With its Proximal Injection Port (PIP™) technology, Chameleon™ is the first and only angioplasty balloon catheter that allows for simultaneous balloon inflation and intravascular injection of fluids while maintaining guidewire access. PIP™ technology incorporates proprietary catheter construction that allows for targeted fluid delivery with an intuitive, easy to use design.

Products and Phases

Product	Phase
Chameleon™	FDA Approved
Chameleon™ uniquely combines a high-pressure balloon catheter with Supervision™ technology – an integrated injection modality that provides targeted injection of diagnostic fluids (such as contrast media) or therapeutic fluids (in the US only). Chameleon™ is intended for use in PTA of the peripheral vasculature, including the femoral, iliac, and renal arteries and for the treatment of obstructive lesions of native or synthetic AV access sites. It allows physicians to visualize by injecting through the atheter, whether the balloon is inflated or deflated, all while maintaining wire position.

	TARGET MARKETS
	Medical Industries.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	21 Habarzel St.
City	Tel Aviv
Country	Israel
Zip	6971029

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Gil Bernstein	VP, Product
Dr. Alexander Yevzlin	Chief Medical Officer
Mr. John Rappe	Chief Business Officer
Ms. Sigal Shachar	CFO	Abital (CFO)
Mr. Ilan Carmel	Co-Founder	EasyGlide (COO)
Dr. Michael Gabriel Tal	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Founding Partner, Access Medical Ventures

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Oct. 10, 2019

Initial Revenues

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed

Sep. 01, 2012

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Holding Company	abCDe
abC Defghij	Investment Company	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2019

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2018

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe